| Ident. | Authors (with country if any) | Title |
|---|
| 000034 (2020) |
Angelika Batta ; Bhupinder Singh Kalra ; Raj Khirasaria | Trends in FDA drug approvals over last 2 decades: An observational study |
| 000070 (2020) |
Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte] | Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein. |
| 000082 (2020) |
Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud] | The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus |
| 000084 (2020) |
Matthew Zirui Tay [Singapour] ; Chek Meng Poh [Singapour] ; Laurent Rénia [Singapour] ; Paul A. Macary [Singapour] ; Lisa F. P. Ng [Singapour, Royaume-Uni] | The trinity of COVID-19: immunity, inflammation and intervention |
| 000129 (2020) |
Mariano Mora-Pereira [États-Unis] ; Eva M. Abarca [États-Unis] ; Sue Duran [États-Unis] ; William Ravis [États-Unis] ; Richard J. Mcmullen [États-Unis] ; Britta M. Fischer [États-Unis] ; Yann-Huei Phillip Lee [États-Unis] ; Anne A. Wooldridge [États-Unis] | Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies |
| 000167 (2020) |
Peter A. Riedell ; Michael R. Bishop | Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas |
| 000193 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000206 (2020) |
Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos | Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations |
| 000207 (2020) |
Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang Qi | Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia |
| 000213 (2020) |
Ludivine Renaud [États-Unis] ; Willian A. Da Silveira [Royaume-Uni] ; Naoko Takamura [États-Unis] ; Gary Hardiman [États-Unis, Royaume-Uni] ; Carol Feghali-Bostwick [États-Unis] | Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis |
| 000249 (2020) |
Mark P. Lythgoe [Royaume-Uni] ; Paul Middleton [Royaume-Uni] | Ongoing Clinical Trials for the Management of the COVID-19 Pandemic |
| 000258 (2020) |
Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni] | New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. |
| 000266 (2020) |
Jessica Vandenhaute [Belgique] ; Carine H. Wouters [Belgique] ; Patrick Matthys [Belgique] | Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome |
| 000269 (2020) |
Jose Manuel Sánchez-Maldonado [Espagne] ; Manuel Martínez-Bueno [Espagne] ; Helena Canhão [Portugal] ; Rob Ter Horst [Pays-Bas] ; Sonia Mu Oz-Pe A [Espagne] ; Ana Mo Iz-Díez [Espagne] ; Ana Rodríguez-Ramos [Espagne] ; Alejandro Escudero [Espagne] ; Signe B. Sorensen [Danemark] ; Merete L. Hetland [Danemark] ; Miguel A. Ferrer [Espagne] ; Bente Glintborg [Danemark] ; Ileana Filipescu [Roumanie] ; Eva Pérez-Pampin [Espagne] ; Pablo Conesa-Zamora [Espagne] ; Antonio García [Espagne] ; Alfons Den Broeder [Pays-Bas] ; Salvatore De Vita [Italie] ; Svend Erik Hove Jacobsen [Danemark] ; Eduardo Collantes [Espagne] ; Luca Quartuccio [Italie] ; Mihai G. Netea [Pays-Bas, Allemagne] ; Yang Li [Pays-Bas] ; João E. Fonseca [Portugal] ; Manuel Jurado [Espagne] ; Miguel Ngel L Pez-Nevot [Espagne] ; Marieke J. H. Coenen [Pays-Bas] ; Vibeke Andersen [Danemark] ; Rafael Cáliz [Espagne] ; Juan Sainz [Espagne] | NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium |
| 000280 (2020) |
Paramarjan Piranavan [États-Unis] ; Manjeet Bhamra [États-Unis] ; Andras Perl [États-Unis] | Metabolic Targets for Treatment of Autoimmune Diseases |
| 000282 (2020) |
Panyang Xu [République populaire de Chine] ; Qi Zhou [République populaire de Chine] ; Jiancheng Xu [République populaire de Chine] | Mechanism of thrombocytopenia in COVID-19 patients |
| 000290 (2020) |
Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Simone Piva [Italie] ; Nicola Latronico [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Paola Gaggia [Italie] ; Ezio Movilli [Italie] ; Sergio Bove [Italie] ; Fabio Malberti [Italie] ; Marco Farina [Italie] ; Martina Bracchi [Italie] ; Ester Maria Costantino [Italie] ; Nicola Bossini [Italie] ; Mario Gaggiotti [Italie] ; Francesco Scolari [Italie] | Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy |
| 000292 (2020) |
Fujun Peng [République populaire de Chine] ; Lei Tu [République populaire de Chine] ; Yongshi Yang [République populaire de Chine] ; Peng Hu [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Qinyong Hu [République populaire de Chine] ; Feng Cao [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Christopher Chang [États-Unis] | Management and Treatment of COVID-19: The Chinese Experience |
| 000299 (2020) |
Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis] | Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties |
| 000307 (2020) |
Ethan S. Sen [Royaume-Uni] ; A V Ramanan [Royaume-Uni] | Juvenile idiopathic arthritis-associated uveitis. |
| 000344 (2020) |
Sadaf Atiqi [Pays-Bas] ; Femke Hooijberg [Pays-Bas] ; Floris C. Loeff [Pays-Bas] ; Theo Rispens [Pays-Bas] ; Gerrit J. Wolbink [Pays-Bas] | Immunogenicity of TNF-Inhibitors |
